Boost For Africa's Malaria Control Strategy Following New Study

The study by the Kenya Medical Research Institute (Kemri) Wellcome Trust Research Programme comes as Kenya seeks an alternative malaria treatment given the emergence of resistance to Artemisinin-based Combination Therapies (ACTs) in South East Asia. The researchers sought to compare standard treatment regimens against double and triple drug combinations to determine their safety and tolerability.

Scientists at the research facility also believe that the possibility of the multi drug-resistant malaria parasites spreading to the Indian subcontinent and to Sub-Saharan Africa as has been the case with chloroquine and sulfadoxine- pyrimethamine (Fansidar) is an ongoing concern. In addition, novel antimalarial compounds that would be used to develop new drugs to combat the multidrug-resistant parasites are not likely to be registered within the next five years, writes Leon Lidigu for The Nation.

InFocus

Mosquito nets (file photo).

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.